Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $158.3M |
| Sales growthchange from the year before | +1031.2% |
| Operating marginshare of sales left after running the business | -32.5% |
| Net marginshare of sales kept as profit | -43.5% |
| Free-cash-flow marginspare cash generated per $100 of sales | -25.3% |
| Return on invested capitalprofit made on each $100 put into the business | -90.7% |
| Return on equityprofit vs. shareholders' accounting value | -154.0% |
| Change in share countnegative = the company is buying back its shares | +9.3% |
3 insiders sold $24.3M (1% under pre-arranged plans) on the open market.
| Adair JasonChief Business Officer | Sold (plan)Jul 27 | 688 shat $87.53 · $60K |
| Boyle DanaChief Accounting Officer | Sold (plan)Jul 27 | 1,600 shat $87.53 · $140K |
| Bloch Stephen MDirector | SoldJul 23 | 100,000 shat $89.48 · $8.9M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy